Polomar Health Services Inc. has announced a significant amendment to its financial agreement with Reprise Management, Inc. As part of a Second Amendment to an existing Promissory Note, the company has reduced its principal debt from $897,549.74 to $597,549.74 using proceeds from the sale of newly designated Series A Convertible Preferred Stock. The remaining balance will now be subject to a simplified annual interest rate of 12%, with the maturity date extended to July 31, 2027. Additionally, Polomar has entered into a Securities Purchase Agreement, issuing 60 shares of the preferred stock to Reprise for $300,000, which will be allocated toward paying down the principal of the Reprise Note. This strategic move aims to streamline the company's debt obligations and improve its financial structure.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.